Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. pregnancy and breastfeeding 2. history of g6pdh deficiency 3. preadmission anticoagulation 4. severe renal insufficiency (glomerular filtration rate \<30 ml/min/1.73m2) 5. medical records of cirrhosis 6. active chronic hepatitis 7. severe hepatic disease defined by got or gpt levels three times above the normal upper limit 8. patients with history of allergic reaction or significant sensitivity to methylene blue 9. treatment with immunosuppressive agents 10. use of other investigational drugs in the moment of inclusion

1. pregnancy and breastfeeding 2. history of g6pdh deficiency 3. preadmission anticoagulation 4. severe renal insufficiency (glomerular filtration rate \<30 ml/min/1.73m2) 5. medical records of cirrhosis 6. active chronic hepatitis 7. severe hepatic disease defined by got or gpt levels three times above the normal upper limit 8. patients with history of allergic reaction or significant sensitivity to methylene blue 9. treatment with immunosuppressive agents 10. use of other investigational drugs in the moment of inclusion

Nov. 16, 2021, 6:30 p.m. usa

pregnancy and breastfeeding history of g6pdh deficiency preadmission anticoagulation severe renal insufficiency (glomerular filtration rate <30 ml/min/1.73m2) medical records of cirrhosis active chronic hepatitis severe hepatic disease defined by got or gpt levels three times above the normal upper limit patients with history of allergic reaction or significant sensitivity to methylene blue treatment with immunosuppressive agents use of other investigational drugs in the moment of inclusion

pregnancy and breastfeeding history of g6pdh deficiency preadmission anticoagulation severe renal insufficiency (glomerular filtration rate <30 ml/min/1.73m2) medical records of cirrhosis active chronic hepatitis severe hepatic disease defined by got or gpt levels three times above the normal upper limit patients with history of allergic reaction or significant sensitivity to methylene blue treatment with immunosuppressive agents use of other investigational drugs in the moment of inclusion

Oct. 26, 2020, 11:31 p.m. usa

1. pregnancy and breastfeeding 2. history of g6pdh deficiency 3. preadmission anticoagulation 4. severe renal insufficiency (glomerular filtration rate <30 ml/min/1.73m2) 5. medical records of cirrhosis 6. active chronic hepatitis 7. severe hepatic disease defined by got or gpt levels three times above the normal upper limit 8. patients with history of allergic reaction or significant sensitivity to methylene blue 9. treatment with immunosuppressive agents 10. use of other investigational drugs in the moment of inclusion

1. pregnancy and breastfeeding 2. history of g6pdh deficiency 3. preadmission anticoagulation 4. severe renal insufficiency (glomerular filtration rate <30 ml/min/1.73m2) 5. medical records of cirrhosis 6. active chronic hepatitis 7. severe hepatic disease defined by got or gpt levels three times above the normal upper limit 8. patients with history of allergic reaction or significant sensitivity to methylene blue 9. treatment with immunosuppressive agents 10. use of other investigational drugs in the moment of inclusion